Fosun's Great Reset: A RMB23.4 Billion Write-Down to Forge a Leaner Future

HONG KONG – March 31, 2026 – Fosun International has undertaken a massive strategic write-down, posting a RMB23.4 billion impairment provision in its 2025 annual results. The move, which pushed the conglomerate to a significant book loss, was framed by Chairman Guo Guangchang not as a sign of distress, but as a deliberate and "prudent accounting measure" to pivot the company toward a more focused and profitable future.

At the company's annual results presentation, Guo described the decision as "repairing the roof on a sunny day," signaling a proactive clean-up of the company's balance sheet. The impairment, a non-cash provision, is intended to clear the way for Fosun's core businesses to shine, unburdened by underperforming assets. This significant financial maneuver marks what the chairman calls a "new stage of development" for the global enterprise.

A Strategic Pruning of the Portfolio

The RMB23.4 billion impairment is a calculated move rooted in a multi-year strategy of streamlining the sprawling conglomerate. The provision is split between two main areas: approximately 55% is tied to real estate projects facing impairment indicators, while the remaining 45% relates to goodwill and intangible assets from certain non-core business segments. This action directly addresses assets that have lagged in profitability and value.

"We will resolutely divest assets with low profitability and value below target, and focus our resources on core, high‑growth areas, steering the Company toward a leaner, healthier, and more sustainable future," Guo Guangchang stated, emphasizing the long-term vision behind the short-term pain of the write-down.

This is not a sudden shift but an acceleration of an existing policy. Between 2022 and 2024, Fosun divested approximately RMB75 billion in non-strategic assets. In 2024 alone, the group signed asset divestment agreements totaling around RMB17.5 billion. The 2025 impairment is the most dramatic step yet in this "streamlining and strengthening" campaign, designed to optimize the company's capital structure and reduce debt. By taking this significant non-cash hit now, Fosun's management believes future operating results will more accurately reflect the underlying strength and quality of its primary business pillars.

Core Engines Powering Through the Overhaul

While the impairment dominated headlines, the operational results from Fosun's core subsidiaries painted a picture of robust health and growth, validating the strategy to concentrate resources on them. The group's four core subsidiaries—Fosun Pharma, Fosun Insurance Portugal, Yuyuan, and Club Med—collectively generated RMB128.2 billion in revenue, accounting for a commanding 74% of the group's total.

Fosun Pharma emerged as a standout performer, achieving a net profit of RMB3.371 billion, a remarkable 21.69% year-on-year increase. This growth was fueled by a strategic focus on innovation and globalization. Revenue from innovative drugs surged by nearly 30% to RMB9.893 billion, becoming a primary engine of its performance. Simultaneously, its global footprint expanded, with overseas revenue climbing 14.87% to account for over 31% of its total revenue, a testament to its evolution into a system-centric global player.

The insurance segment also demonstrated resilience and growth. Fosun Insurance Portugal delivered a net profit of EUR201 million, up 15.8% from the previous year. The insurer has successfully leveraged Fosun's global network to expand beyond Europe into Latin America and Africa. Its financial strength was further affirmed in 2025 when it received its first-ever 'A' rating from S&P Global, a significant international endorsement of its asset quality and risk management.

In the tourism sector, Club Med achieved record-high results, with revenue reaching approximately RMB18 billion and operating profit growing 4.6% to RMB1.44 billion. The brand's success is driven by strong global demand for its premium all-inclusive and mountain vacation offerings. With 67 resorts worldwide, Club Med is continuing its strategic expansion with new openings and renovations, capitalizing on the post-pandemic travel boom and the rising trend of experiential, luxury tourism.

A Reckoning with China's Property Market

The significant portion of the impairment—approximately 55%—linked to real estate serves as a stark reflection of the persistent challenges within China's property sector. Fosun's write-down is not an isolated event but a consequence of a broader market downturn that continued through 2025. The Chinese real estate industry has been grappling with weak market demand, significant oversupply, and falling prices.

Throughout 2025, vacancy rates in commercial real estate rose, particularly in second-tier cities, while rental income declined as consumer confidence remained weak and retailers adopted cautious expansion plans. While government stimulus measures provided some support, they were not enough to trigger a broad-based recovery. In this environment, large-scale asset revaluations and impairments have become a necessary reality for companies with significant real estate exposure.

Fosun's impairment on its real estate projects, including those under its Yuyuan subsidiary, is a direct response to these market conditions. However, the company is also actively seeking to optimize its property portfolio. A key part of this strategy includes the planned spin-off of its luxury hospitality asset, Atlantis Sanya, for a listing as a Real Estate Investment Trust (REIT) on the Shanghai Stock Exchange. This move aims to monetize a prime asset and unlock value, aligning with the broader goal of becoming a more asset-light organization.

Fortifying Investor Confidence for the Long Haul

In the wake of the announcement, Fosun's leadership has moved swiftly to reassure investors and signal its unwavering confidence in the company's long-term value. A key measure is the board's approval of a share buyback program of up to HKD1 billion. This action is underpinned by the management's belief that the company's current share price does not reflect its intrinsic worth, particularly with an adjusted net asset value (NAV) per share standing at a robust HKD18.1.

"I believe Fosun has the ability to navigate through cycles," Guo said. "While we may face some short-term challenges, these efforts will position Fosun for steadier, longer-term growth."

Further bolstering this message, Fosun's major shareholder and senior management team have committed to increasing their personal holdings in the company's shares. This alignment of interests between management and shareholders is a powerful statement of belief in the strategic pivot. Looking ahead, Fosun has also indicated it will explore additional measures to reward shareholders, including optimizing its dividend mechanism as operational improvements and cash flow conditions permit, reinforcing its commitment to delivering sustainable value as it emerges from this period of strategic transformation.